CARNEGIE MELLON UNIVERSITY - Q2 2022 holdings

$199 Million is the total value of CARNEGIE MELLON UNIVERSITY's 6 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .

 Value Shares↓ Weighting
IEMG BuyISHARES INCcore msci emkt$144,874,000
-10.6%
2,953,000
+1.2%
72.83%
+7.5%
SellDUOLINGO INC$52,725,000
-29.4%
602,233
-23.3%
26.51%
-15.1%
NBSE  NEUBASE THERAPEUTICS INC$986,000
-44.2%
939,4120.0%0.50%
-32.9%
VERA  VERA THERAPEUTICS INCcl a$219,000
-41.9%
16,0600.0%0.11%
-30.4%
 PREDICTIVE ONCOLOGY INC$85,000
-57.9%
207,1440.0%0.04%
-48.8%
IHT  INNSUITES HOSPITALITY TRsh ben int$29,000
-6.5%
10,0000.0%0.02%
+15.4%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-05
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES INC8Q3 202379.8%
DUOLINGO INC8Q3 202377.3%
NEUBASE THERAPEUTICS INC.8Q3 20231.1%
VERA THERAPEUTICS INC.8Q3 20230.4%
PREDICTIVE ONCOLOGY INC.8Q3 20230.1%
INNSUITES HOSPITALITY TRUST8Q3 20230.0%
CARMELL THERAPEUTICS CORP1Q3 20230.5%

View CARNEGIE MELLON UNIVERSITY's complete holdings history.

Latest significant ownerships (13-D/G)
CARNEGIE MELLON UNIVERSITY Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
NeuBase Therapeutics, Inc.July 22, 2019939,4125.5%

View CARNEGIE MELLON UNIVERSITY's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-02
13F-HR2023-11-01
13F-HR2023-08-01
13F-HR2023-05-03
13F-HR2023-02-07
13F-HR2022-11-10
13F-HR2022-08-05
13F-HR2022-05-10
13F-HR2022-02-11
SC 13G2019-07-22

View CARNEGIE MELLON UNIVERSITY's complete filings history.

Compare quarters

Export CARNEGIE MELLON UNIVERSITY's holdings